Scientists test stem cell shot to halt blinding eye disease

NCT ID NCT03178149

Recruiting now Disease control Sponsor: Astellas Institute for Regenerative Medicine Source: ClinicalTrials.gov ↗

Summary

This is an early-stage study to check the safety of a new treatment called ASP7317 for people with advanced dry age-related macular degeneration (AMD), a condition that causes central vision loss. The treatment involves injecting lab-grown retinal cells under the damaged part of the eye, with the hope they will replace lost cells and slow disease progression. About 42 participants with moderate to severe vision loss will receive one of three doses and be closely monitored for one year for safety and any signs of vision improvement.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Deep Blue Retina
RECRUITING

Southaven, Mississippi, 38671, United States
Emory University Eye Center
RECRUITING

Atlanta, Georgia, 30322, United States
Jules Stein Eye Institute
RECRUITING

Los Angeles, California, 90095, United States
Kaiser Permanente Riverside Medical Center
RECRUITING

Riverside, California, 92505, United States
Mass Eye and Ear Infirmary Ophthalmology Clinical Research Office
WITHDRAWN

Boston, Massachusetts, 02114, United States
Mid-Atlantic Retina
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
NJ Retina
WITHDRAWN

New Brunswick, New Jersey, 08901, United States
Ophthalmic Consultants of Boston
RECRUITING

Boston, Massachusetts, 02114, United States
Retina Consultants of Southwest Florida & National Ophthalmic Research Institute
WITHDRAWN

Fort Myers, Florida, 33912, United States
Retina Foundation of the Southwest
RECRUITING

Dallas, Texas, 75231, United States
Retina Specialty Institute
RECRUITING

Pensacola, Florida, 35203, United States
Retinal Consultants of Arizona LTD, Retinal Research Institute
WITHDRAWN

Phoenix, Arizona, 85053, United States
Spokane Eye Clinical Research
RECRUITING

Spokane, Washington, 99204, United States
Stanford University Byers Eye Institute
RECRUITING

Palo Alto, California, 94303, United States
Tennessee Retina, PC
WITHDRAWN

Nashville, Tennessee, 37203, United States
University Retina and Macula Associates
RECRUITING

Oak Forest, Illinois, 60452, United States
University of Michigan Kellog Eye Center
RECRUITING

Ann Arbor, Michigan, 48105, United States
University of Washington
WITHDRAWN

Seattle, Washington, 98104, United States
Valley Retina Institute
COMPLETED

McAllen, Texas, 78503, United States

Conditions

Explore the condition pages connected to this study.

AGE-RELATED MACULAR DEGENERATION